Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide.

"Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: B.N. has no conflicts of interest to declare. F.B. has no conflicts of interest to declare. E.T. reports paid consultancy from Arvelle, Argenx, Angelini, Clexio, UCB, Eisai, Epilog, Bial, Medtronic, Everpharma, Biogen, Takeda, Liva-Nova, Newbridge, Sunovion, GW Pharmaceuticals/Jazz, and Marinus; research funding (directly, or to institution) from GSK, Biogen, Eisai, Novartis, Red Bull, Bayer, and UCB; speaker’s honoraria from Arvelle, Angelini, GSK, GW Pharmaceuticals/Jazz, Böhringer Ingelheim, Eisai, Epilog, Bial, Everpharma, UCB, Liva-Nova, Newbridge, Hikma, Novartis, and Sanofi. He is CEO of Neuroconsult Ges.m.b.H. and received grants from Austrian Science Fund (FWF), Österreichische Nationalbank, European Union. G.K. received travel support from Cyberonics, UCB, and Eisai. She received speaker’s honoraria from Eisai. Her institution received funding from Bayer, Biogen-Idec, Eisai, GSK, Novartis, Red Bull, and UCB."

"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."